mdxhealth (@mdxhealth) header
mdxhealth (@mdxhealth) profile picture

Mdxhealth is a molecular diagnostics company that develops and commercializes advanced tests for cancer assessment and the personalized treatment of patients

Irvine, CA
Joined November 2010
Medicine is increasingly embracing genomic and biomarker insights. By combining clinical factors with molecular information, physicians can gain a more personalized view of disease and make informed decisions throughout the care journey. ow.ly/XK7w50ZEWVu
32
A negative prostate biopsy doesn’t always rule out cancer. Confirm mdx analyzes existing biopsy tissue at the molecular level to help assess the risk of undetected prostate cancer and inform next steps. ow.ly/3NKG50ZEWSf
34
Every test performed, patient helped, and doctor served could not be done without the people behind mdxhealth. We're proud of the expertise & collaboration that drive progress forward every single day. Interested in joining the mission? We're #hiring. mdxhealth.com/careers/
44
We're onsite at #LUGPA and excited to connect with providers, practice leaders, and industry colleagues. If you haven't stopped by our booth #103 yet, we'd love to meet you and discuss the latest developments in prostate cancer diagnostics and patient care.
1
57
PSA can help identify prostate cancer risk, but it doesn’t always tell the full story. Exo mdx is a non-invasive urine test that provides individualized risk information before biopsy, supporting more informed decisions about next steps. ow.ly/LIIC50ZEVYj
51
#Movember is about more than the mustache—it’s about #MensHealth, early detection, informed care, and supporting men through critical health decisions. This month, we’re spotlighting #ProstateCancer and more. mdxhealth.com/tests/
38
Confirm mdx analyzes tissue from the existing biopsy at the molecular level to help assess the risk of undetected prostate cancer and support decisions about whether further evaluation may be appropriate. ow.ly/oPT650ZEVom
57
Timely, actionable insights can support more informed prostate cancer decisions—from risk assessment through treatment planning. ow.ly/2umQ50ZEVle
40
Heading to #LUGPA2026? Stop by booth #103 to learn how #mdxhealth is helping support clinical decision-making across the prostate cancer care pathway. We look forward to connecting!
44
Not all prostate cancers behave the same. GPS mdx analyzes tumor biology to provide insight into how an individual’s cancer may behave, supporting personalized treatment discussions and care planning. ow.ly/s4MI50ZEVjR
45
Heading to #LUGPA2026 in Chicago! We're excited to connect with urology leaders and share how #mdxhealth is advancing personalized prostate cancer care through actionable diagnostic insights. Stop by booth #103 and say hello. We look forward to seeing you there!
49
Prostate cancer care is a team effort. We’re grateful for the urologists, nurses, laboratory professionals, patient advocates, and countless others whose expertise and compassion support patients every day. Thank you for all that you do.
39
An elevated PSA can raise questions. For patients considering biopsy, Exo mdx provides personalized risk information through a simple, non-invasive urine test—helping inform more confident decisions together. ow.ly/K9MV50ZEUZO
66
Prostate cancer decisions happen at key points—from biopsy to risk assessment to treatment planning. Our portfolio provides actionable insights to support more informed care. mdxhealth.com/tests/
51
At mdxhealth, our mission is to help physicians and patients navigate critical prostate cancer decisions. Behind that mission is a team of dedicated experts working together to make a meaningful impact. Interested in joining us? We’re #hiring. ow.ly/E1xp50ZEULP
52
Xpert One Support helps patients and healthcare teams navigate the testing process with responsiveness, convenience, expertise, and compassion. Supporting informed care means supporting the people behind every decision. mdxhealth.com/xpert-one/
40
Some prostate cancers grow slowly, while others may be more aggressive. Understanding how a patient’s cancer is likely to behave can help inform treatment planning and long-term management. Personalized information can support personalized care. ow.ly/GQw950ZEUzl
58
#ProstateCancer Awareness Month may be ending, but today’s conversations shape decisions for months and years to come. Thank you to the physicians, patients, caregivers, and advocates advancing informed care and improving outcomes.
58
After a positive biopsy, key decisions follow. GPS mdx analyzes tumor biology to help inform personalized treatment discussions and care planning. mdxhealth.com/gps-physician/
51
Every patient deserves to feel informed and empowered. From PSA results to biopsy decisions and treatment options, better understanding helps support shared decision-making with their care team. mdxhealth.com/tests/
50